Status:

COMPLETED

Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

Depressive Disorder, Major

Cannabis Abuse

Eligibility:

All Genders

14-25 years

Phase:

PHASE2

Brief Summary

Adolescents who are diagnosed with major depressive disorder are often also diagnosed with marijuana dependence. Fluoxetine is an antidepressant medication currently used to treat young people who are...

Detailed Description

Marijuana dependence is the most common illicit substance use disorder in the United States. Its prevalence is highest among adolescents and young adults. Major depressive disorder is one of the most ...

Eligibility Criteria

Inclusion

  • DSM-IV diagnosis of current marijuana abuse or dependence, confirmed by SCID-SUD
  • DSM-IV diagnosis of current major depressive disorder, confirmed by the K-SADS
  • Marijuana use of at least two days within the week prior to enrollment
  • Demonstrated adequate levels of depressive symptoms within the week prior to enrollment

Exclusion

  • DSM-IV diagnosis of bipolar disorder, schizoaffective disorder, or schizophrenia
  • Hypo or hyperthyroidism
  • Significant cardiac, neurological, or kidney impairment
  • Liver disease (SGOT, SGPT, or gamma-GTP greater than 3 times the normal level)
  • Use of antipsychotic or antidepressant medication in the month prior to enrollment
  • DSM-IV dependence on any substance except marijuana or nicotine; alcohol dependence, or history of drug use
  • History of significant medication side effects from any SSRI antidepressant
  • Pregnant
  • Unable to use adequate contraceptive methods for the duration of the study
  • Inability to read or understand English

Key Trial Info

Start Date :

September 1 2004

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2012

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT00149643

Start Date

September 1 2004

End Date

December 1 2012

Last Update

June 24 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Psychiatry

Pittsburgh, Pennsylvania, United States, 15213